Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Bryan Stuart is recorded as COO, CEO and Board Member at Fulcrum Therapeutics, Inc. (FULC). The proxy statement of Fulcrum Therapeutics, Inc. reports total compensation of $1,869,696 for Bryan Stuart in fiscal 2023, including a base salary of $2,385. Disclosed compensation is on record for 5 fiscal years. Bryan Stuart has spoken on 9 earnings calls across 1 company, most recently for Fulcrum Therapeutics, Inc. on August 11, 2022.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2021-03-31–present
2021-03-31–present
Recorded roles and call appearances connecting this person to public companies.
COO, CEO, Board Member
2021-03-31–present
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Fulcrum Therapeutics, Inc. (FULC) | Former President and Chief Executive Officer | $2,385 | $1,869,696 |
| 2022 | Fulcrum Therapeutics, Inc. (FULC) | Former President and Chief Executive Officer | $572,450 | $3,971,756 |
| 2021 | Fulcrum Therapeutics, Inc. (FULC) | Former President and Chief Executive Officer | $515,376 | $5,055,104 |
| 2020 | Fulcrum Therapeutics, Inc. (FULC) | Chief Operating Officer | $440,000 | $1,774,715 |
| 2019 | Fulcrum Therapeutics, Inc. (FULC) | Chief Operating Officer | $406,823 | $1,234,960 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
